Abstract
Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 636-638 |
| Number of pages | 3 |
| Journal | Antimicrobial Agents and Chemotherapy |
| Volume | 14 |
| Issue number | 4 |
| DOIs | |
| State | Published - Jan 1 1978 |
Fingerprint
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases
Cite this
Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole. / Rissing, John Peter; Newman, Cheryl L; Moore, W. L.
In: Antimicrobial Agents and Chemotherapy, Vol. 14, No. 4, 01.01.1978, p. 636-638.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Artifactual depression of serum glutamic oxaloacetic transaminase by metronidazole
AU - Rissing, John Peter
AU - Newman, Cheryl L
AU - Moore, W. L.
PY - 1978/1/1
Y1 - 1978/1/1
N2 - Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.
AB - Eighteen patients developed abnormally low serum glutamic oxaloacetic transaminase values during metronidazole absorbs at 340 nm, simulating reduced nicotinamide adenine dinucleotide, which is the final colorimetric product of the serum glutamic oxaloacetic transaminase assay.
UR - http://www.scopus.com/inward/record.url?scp=0018084560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0018084560&partnerID=8YFLogxK
U2 - 10.1128/AAC.14.4.636
DO - 10.1128/AAC.14.4.636
M3 - Article
VL - 14
SP - 636
EP - 638
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
SN - 0066-4804
IS - 4
ER -